Phase II trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: A study of the Spanish Group for Research on Sarcomas (GEIS)
Open Access
- 1 August 1998
- journal article
- clinical trial
- Published by Elsevier BV in Annals Of Oncology
- Vol. 9 (8), 871-876
- https://doi.org/10.1023/a:1008474802882
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Synovial sarcoma. Uniform response of metastases to high dose ifosfamideCancer, 1994
- Prophylaxis and reversal of ifosfamide encephalopathy with methylene-blueThe Lancet, 1994
- Comparative pharmacokinetics of ifosfamide, 4-hydroxyifosfamide, chloroacetaldehyde, and 2- and 3-dechloroethylifosfamide in patients on fractionated intravenous ifosfamide therapyCancer Chemotherapy and Pharmacology, 1993
- Chemotherapy in the multidisciplinary approach to soft tissue sarcomasAnnals Of Oncology, 1992
- Fractionated ifosfamide therapy produces a time‐dependent increase in ifosfamide metabolism.British Journal of Clinical Pharmacology, 1990
- Response to ifosfamide and mesna: 124 previously treated patients with metastatic or unresectable sarcoma.Journal of Clinical Oncology, 1989
- Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomasEuropean Journal of Cancer and Clinical Oncology, 1987
- Therapeutic effects of single-push or fractionated injections or continuous infusion of oxazaphosphorines (cyclophosphamide, ifosfamide, Asta Z 7557)Cancer, 1984
- High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcomaCancer Chemotherapy and Pharmacology, 1983
- Reporting results of cancer treatmentCancer, 1981